Unknown

Dataset Information

0

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.


ABSTRACT: The spontaneous autoimmune peripheral polyneuropathy (SAPP) model in B7-2 knockout non-obese diabetic mice shares clinical and histological features with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Secondary axonal loss is prominent in the progressive phase of this neuropathy. Neurotrophin 3 (NT-3) is an important autocrine factor supporting Schwann cell survival and differentiation and stimulates neurite outgrowth and myelination. The anti-inflammatory and immunomodulatory effects of NT-3 raised considerations of potential efficacy in the SAPP model that could be applicable to CIDP. For this study, scAAV1.tMCK.NT-3 was delivered to the gastrocnemius muscle of 25-week-old SAPP mice. Measurable NT-3 levels were found in the serum at 7-week postgene delivery. The outcome measures included functional, electrophysiological and histological assessments. At week 32, NT-3-treated mice showed increased hind limb grip strength that correlated with improved compound muscle action potential amplitude. Myelinated fiber density was 1.9 times higher in the NT-3-treated group compared with controls and the number of demyelinated axons was significantly lower. The remyelinated nerve fiber population was significantly increased. These improved histopathological parameters from scAAV1.tMCK.NT-3 treatment occurred in the setting of reduced sciatic nerve inflammation. Collectively, these findings suggest a translational application to CIDP.

SUBMITTER: Yalvac ME 

PROVIDER: S-EPMC4696906 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

Yalvac M E ME   Arnold W D WD   Braganza C C   Chen L L   Mendell J R JR   Sahenk Z Z  

Gene therapy 20150630 1


The spontaneous autoimmune peripheral polyneuropathy (SAPP) model in B7-2 knockout non-obese diabetic mice shares clinical and histological features with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Secondary axonal loss is prominent in the progressive phase of this neuropathy. Neurotrophin 3 (NT-3) is an important autocrine factor supporting Schwann cell survival and differentiation and stimulates neurite outgrowth and myelination. The anti-inflammatory and immunomodulatory  ...[more]

Similar Datasets

| S-EPMC5883061 | biostudies-literature
| S-EPMC10042697 | biostudies-literature
| S-EPMC5884804 | biostudies-literature
| S-EPMC4089012 | biostudies-literature
| S-EPMC3944324 | biostudies-literature
| S-EPMC10570084 | biostudies-literature
| S-EPMC3895684 | biostudies-literature
| S-EPMC9013664 | biostudies-literature
| S-EPMC6695161 | biostudies-literature
| S-EPMC4402272 | biostudies-literature